Pharmacodynamic biomarkers responsive to mutant huntingtin lowering in a Huntington's disease mouse model
Source
Neurobiology of disease - ISSN 0969-9961-209 (2025) p. 1-13
In vivo and ex vivo biodistribution data of [18F]CHDI-650 in mice
Source
Mendeley Data, 2024,
Preclinical evaluation of the novel [18F]CHDI-650 PET ligand for non-invasive quantification of mutant huntingtin aggregates in Huntington's disease
Source
Mendeley Data, 2024,
Biodistribution and dosimetry of the PET radioligand [¹⁸F]CHDI-650 in mice for detection of mutant huntingtin aggregates
Source
EJNMMI research - ISSN 2191-219X-14:1 (2024) p. 1-12
Preclinical evaluation of the novel [¹⁸F]CHDI-650 PET ligand for non-invasive quantification of mutant huntingtin aggregates in Huntington's disease
Source
European journal of nuclear medicine and molecular imaging - ISSN 1619-7070-52:1 (2024) p. 122-133